Dualsystems
Publication and more
We identify targets / off-targets of your ligand
If you want to get support for your project
LRC-TriCEPS customers worldwide
Over 200 satisfied customers from 28 countries.
LRC-TriCEPS publications worldwide
Contact form
Please fill out all mandatory (*) fields.
Footer
Social Media
Affinity and receptor expression limits tested for LRC-TriCEPS
Dualsystems Biotech AG is testing the limits of the LRC-TriCEPSTM (CaptiRec) technology using antibodies with different affinities against the same target and cells expressing the target receptor with different expression levels. Details of the assesment see here
BIO-Europe Spring® Conference in Paris/France 2015, March 9-11
BIO-Europe Spring® Conference in Paris/France 2015, March 9-11. For a face to face meeting to learn more about Dualsystems and its new technology to identify receptors of your ligand on living cells please send a meeting invitation via the conference partnering system to Dr. Paul Helbling. Alternatively, you can reach Dr. Paul Helbling via email…
Dualsystems Biotech AG and Biaffin GmbH & Co KG perform together an example of an experiment
Dualsystems Biotech AG and Biaffin GmbH & Co KG perform together an example of an experiment. In the case study Dualsystems Biotech AG determined the targets of the Anti EGFR antibodies and Biaffin GmbH& Co KG measured the binding characteristics of the ligand receptor interaction using Surface Plasmon Resonance (SPR).